Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
VSPharmTech Co.,Ltd.
VSPharmTech Co.,Ltd.
AstraZeneca
Sapience Therapeutics
AstraZeneca
BPGbio
Hoffmann-La Roche
AstraZeneca
Coordination Pharmaceuticals, Inc.
BeiGene
Basilea Pharmaceutica
OX2 Therapeutics
Adaptimmune
AbbVie
Bavarian Nordic
Pfizer
EpicentRx, Inc.
SynerGene Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc
Jiangsu HengRui Medicine Co., Ltd.
Boston Scientific Corporation
AbbVie
Mallinckrodt
Hoffmann-La Roche
Cavion
InSightec
Oncolys BioPharma Inc
AbbVie
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Eli Lilly and Company
Sanofi
BioVex Limited
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Shenzhen SiBiono GeneTech Co.,Ltd
Merck Sharp & Dohme LLC
GlaxoSmithKline
Xoft, Inc.
Eli Lilly and Company
Eli Lilly and Company
Boneca Corporation
AstraZeneca